These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 29428470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.
    Hoffman JM, Tyler K, MacEachern SJ, Balemba OB, Johnson AC, Brooks EM, Zhao H, Swain GM, Moses PL, Galligan JJ, Sharkey KA, Greenwood-Van Meerveld B, Mawe GM.
    Gastroenterology; 2012 Apr; 142(4):844-854.e4. PubMed ID: 22226658
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects and sites of action of a M1 receptor positive allosteric modulator on colonic motility in rats and dogs compared with 5-HT4 agonism and cholinesterase inhibition.
    Tsukimi Y, Pustovit RV, Harrington AM, Garcia-Caraballo S, Brierley SM, Di Natale M, Molero JC, Furness JB.
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13866. PubMed ID: 32337809
    [Abstract] [Full Text] [Related]

  • 8. Prokinetic actions of luminally acting 5-HT4 receptor agonists.
    Konen JR, Haag MM, Guseva D, Hurd M, Linton AA, Lavoie B, Kerrigan CB, Joyce E, Bischoff SC, Swann S, Griffin L, Matsukawa J, Falk MD, Gibson TS, Hennig GW, Wykosky J, Mawe GM.
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14026. PubMed ID: 33185015
    [Abstract] [Full Text] [Related]

  • 9. Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension.
    Greenwood-Van Meerveld B, Venkova K, Hicks G, Dennis E, Crowell MD.
    Neurogastroenterol Motil; 2006 Jan; 18(1):76-86. PubMed ID: 16371086
    [Abstract] [Full Text] [Related]

  • 10. Involvement of 5-HT3 and 5-HT4 receptors in colonic motor patterns in rats.
    Yu Y, Chen JH, Li H, Yang Z, Du X, Hong L, Liao H, Jiang L, Shi J, Zhao L, Tan S, Luo H, Huizinga JD.
    Neurogastroenterol Motil; 2015 Jul; 27(7):914-28. PubMed ID: 25807879
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
    Kanazawa M, Watanabe S, Tana C, Komuro H, Aoki M, Fukudo S.
    Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
    [Abstract] [Full Text] [Related]

  • 13. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N, Hosoki K.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [Abstract] [Full Text] [Related]

  • 14. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    Beattie DT, Smith JA, Marquess D, Vickery RG, Armstrong SR, Pulido-Rios T, McCullough JL, Sandlund C, Richardson C, Mai N, Humphrey PP.
    Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
    [Abstract] [Full Text] [Related]

  • 15. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C, Pelosini I.
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.
    Spohn SN, Bianco F, Scott RB, Keenan CM, Linton AA, O'Neill CH, Bonora E, Dicay M, Lavoie B, Wilcox RL, MacNaughton WK, De Giorgio R, Sharkey KA, Mawe GM.
    Gastroenterology; 2016 Nov; 151(5):933-944.e3. PubMed ID: 27480173
    [Abstract] [Full Text] [Related]

  • 18. The effects of prucalopride on postoperative ileus in guinea pigs.
    Park SJ, Choi EJ, Yoon YH, Park H.
    Yonsei Med J; 2013 Jul; 54(4):845-53. PubMed ID: 23709417
    [Abstract] [Full Text] [Related]

  • 19. Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndrome.
    Cole P, Rabasseda X.
    Drugs Today (Barc); 2004 Dec; 40(12):1013-30. PubMed ID: 15645012
    [Abstract] [Full Text] [Related]

  • 20. Effects of the enterokinetic prucalopride (R093877) on colonic motility in fasted dogs.
    Briejer MR, Prins NH, Schuurkes JA.
    Neurogastroenterol Motil; 2001 Oct; 13(5):465-72. PubMed ID: 11696108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.